The choice of the noninferiority margin in clinical trials was driven by baseline risk, type of primary outcome, and benefits of new treatment. [electronic resource]

By: Contributor(s): Producer: 20160429Description: 1144-51 p. digitalISSN:
  • 1878-5921
Subject(s): Online resources: In: Journal of clinical epidemiology vol. 68
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.